Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy have?
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy has 145 citations in the OpenAlex counts ScholarIQ stores.
When was Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy published?
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy has 2011 year in the ScholarIQ index.
What is the open-access status of Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy has closed oa status in the ScholarIQ index.
What is the DOI of Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?
The DOI for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is on the source record.
What is the PMID of Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?
The PMID for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is on the source record.
What is the OpenAlex record for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy?
The OpenAlex for Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy is on the source record.